Search

everythinglearnresearchcommunity

for

Search:↓

Women experience more side effects and have worse blood pressure control from hypertension treatments than men, despite using different medications.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Use minoxidil for hair loss; finasteride and dutasteride for men, dutasteride for women.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Uterine transplants for transgender women are feasible but need more research.

Finasteride reduces prostate size and PSA levels in young patients.

Adult hair follicle cells can create new hair follicles from corneal cells with the right support.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

Hair loss in men is common, treatable, but not curable.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

Addressing underrepresentation in Parkinson's research is crucial for better treatments and understanding.